Market Research Logo

Biohit Oyj (BIOBV) - Product Pipeline Analysis, 2018 Update

Summary

Biohit Oyj (Biohit) is a biotechnology company which offers research and early diagnosis processing products. The company’s products include acetaldehyde binding products, diagnostic tests, dysbiosis test, microplate readers and washers, monoclonal antibodies, and pipettes. It targets therapeutic areas such as gastric cancer, gastroesophageal reflux disease and colorectal cancer, among others. Biohit provides analyses of non-alcoholic and alcoholic beverages and carcinogenic acetaldehyde in foodstuff. The company also offers tests for the diagnosis of lactose intolerance and helicobacter pylori infection. It has presence in Finland, Italy and the UK. Biohit is headquartered in Helsinki, Finland.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Biohit Oyj
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Biohit Oyj Company Overview
Biohit Oyj Company Snapshot
Biohit Oyj Pipeline Products and Ongoing Clinical Trials Overview
Biohit Oyj – Pipeline Analysis Overview
Biohit Oyj - Key Facts
Biohit Oyj - Major Products and Services
Biohit Oyj Pipeline Products by Development Stage
Biohit Oyj Pipeline Products Overview
Celiac Disease Quick Test
Celiac Disease Quick Test Product Overview
GastroPanel Quick Test
GastroPanel Quick Test Product Overview
Lactose Intolerance Quick Test
Lactose Intolerance Quick Test Product Overview
Biohit Oyj - Key Competitors
Biohit Oyj - Key Employees
Biohit Oyj - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Recent Developments
Biohit Oyj, Recent Developments
Apr 30, 2018: Changes to Biohit Oyj’s Management Team
Feb 28, 2018: Biohit Group Financial Statement Release 2017
Feb 22, 2018: Biohit GastroPanel test helps reducing unnecessary gastroscopies in pre-operative evaluation of the patients referred for bariatric surgery
Feb 20, 2018: Changes to Biohit Oyj’s Management Team
Sep 11, 2017: An important patent granted to Biohit Acetium Capsule in Japan
Sep 04, 2017: A new meta-analysis from independent scientists in Italy confirms the accuracy of Biohit GastroPanel in diagnosis of atrophic gastritis
Aug 17, 2017: Biohit Group Half Year Financial Report 2017
Aug 16, 2017: Biohit GastroPanel was shown to be an accurate predictor of gastric cancer risk during a 12-year follow-up of 12.000 people in China
May 04, 2017: Lea Paloheimo appointed Biohit Oyj’s R&D and production director
Feb 20, 2017: Biohit Group Financial Statement Release 2016
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Biohit Oyj Pipeline Products and Ongoing Clinical Trials Overview
Biohit Oyj Pipeline Products by Equipment Type
Biohit Oyj Pipeline Products by Indication
Biohit Oyj, Key Facts
Biohit Oyj, Major Products and Services
Biohit Oyj Number of Pipeline Products by Development Stage
Biohit Oyj Pipeline Products Summary by Development Stage
Celiac Disease Quick Test - Product Status
Celiac Disease Quick Test - Product Description
GastroPanel Quick Test - Product Status
GastroPanel Quick Test - Product Description
Lactose Intolerance Quick Test - Product Status
Lactose Intolerance Quick Test - Product Description
Biohit Oyj, Key Employees
Biohit Oyj, Subsidiaries
Biohit Oyj, Joint Venture
Glossary
List of Figures
Biohit Oyj Pipeline Products by Equipment Type
Biohit Oyj Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report